DANIEL DOWNING: Open Payments
NPI 1134664691 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 49 payments from 17 companies in 2025. Trend: 2023 $765 · 2024 $1,051 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $186 |
| Lilly USA, LLC | 6 | $105 |
| Edwards Lifesciences Corporation | 3 | $100 |
| Novo Nordisk Inc | 5 | $93 |
| Abbott Laboratories | 3 | $71 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Exact Sciences Corporation | 3 | $66 |
| Eisai Inc. | 3 | $61 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
Products named: UBRELVY, SAPIEN 3 Ultra RESILIA, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, QULIPTA, Leqembi, JARDIANCE, MOUNJARO.
Industry payments across OH — which companies pay providers there.
